164 related articles for article (PubMed ID: 858125)
1. Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.
Goldman RL; Jones SE; Heusinkveld RS
Cancer; 1977 May; 39(5):1955-8. PubMed ID: 858125
[TBL] [Abstract][Full Text] [Related]
2. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.
Azizi F; Bitran J; Javehari G; Herbst AL
Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer.
Saiontz HI; Dalton RJ; Eagan RT
Cancer Treat Rep; 1977; 61(3):481-3. PubMed ID: 194692
[No Abstract] [Full Text] [Related]
4. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Van Dyk JJ; Falkson G
Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
[TBL] [Abstract][Full Text] [Related]
5. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT
Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
[No Abstract] [Full Text] [Related]
6. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
Cohen SM; Greenspan EM; Ratner LH; Weiner MJ
Cancer; 1977 Jan; 39(1):41-4. PubMed ID: 832250
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Krikorian JG; Portlock CS; Rosenberg SA
Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma in the adult: effective combination chemotherapy.
Dosik GM; Rodriguez V; Benjamin RS; Bodey GP
Cancer; 1978 Jan; 41(1):56-63. PubMed ID: 626943
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors.
Cangir A; Morgan SK; Land VJ; Pullen J; Starling SA; Nitschke R
Med Pediatr Oncol; 1976; 2(2):183-90. PubMed ID: 958160
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with vincristine sulfate (NSC-67574) and cyclophosphamide (NSC-26271) for generalized malignant schwannoma--a case report.
Valdes OS; Maurer HM
Cancer Chemother Rep; 1970 Feb; 54(1):65-8. PubMed ID: 5527013
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
McKelvey EM; Luce JK; Talley RW; Hersh EM; Hewlett JS; Moon TE
Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
[TBL] [Abstract][Full Text] [Related]
13. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
[TBL] [Abstract][Full Text] [Related]
14. New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Lokich JJ; Frei E; Jaffe N; Tullis J
Cancer; 1976 Aug; 38(2):667-71. PubMed ID: 61797
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Case DC; Young CW; Lee BJ
Cancer; 1977 Apr; 39(4):1382-6. PubMed ID: 66972
[TBL] [Abstract][Full Text] [Related]
16. First, second and third line chemotherapy programs in metastatic breast carcinoma.
Rizel S; Sulkes A; Gez E; Brufman G; Biran S
Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
[TBL] [Abstract][Full Text] [Related]
17. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
Carmo-Pereira J; Oliveira Costa F; Pimentel P
Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
[No Abstract] [Full Text] [Related]
18. Advances in the chemotherapy of soft tissue sarcomas.
Benjamin RS; Baker LH; O'Bryan RM; Moon TE; Gottlieb JA
Med Clin North Am; 1977 Sep; 61(5):1039-43. PubMed ID: 895246
[No Abstract] [Full Text] [Related]
19. Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.
McKelvey EM; Luce JK; Vaitkevicius VK; Talley RW; Bodey GP; Lane M; Moon TE
Cancer; 1977 Jan; 39(1):5-10. PubMed ID: 832251
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of metastatic malignant melanoma (author's transl)].
Kühböck J; Pehamberger H; Mach K; Diem E; Kokoschka EM; Pötzi P
Wien Klin Wochenschr; 1978 Dec; 90(24):856-8. PubMed ID: 84441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]